PDB Short entry for 4EZ5 HEADER TRANSFERASE/TRANSFERASE INHIBITOR 02-MAY-12 4EZ5 TITLE CDK6 (MONOMERIC) IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYCLIN-DEPENDENT KINASE 6; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1-301; COMPND 5 SYNONYM: CELL DIVISION PROTEIN KINASE 6, SERINE/THREONINE-PROTEIN COMPND 6 KINASE PLSTIRE; COMPND 7 EC: 2.7.11.22; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CDK6, CDKN6; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PROTEIN KINASE, ATP BINDING, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.CHOPRA,M.XU REVDAT 4 13-SEP-23 4EZ5 1 REMARK SEQADV REVDAT 3 24-JAN-18 4EZ5 1 REMARK REVDAT 2 24-SEP-14 4EZ5 1 JRNL REVDAT 1 06-FEB-13 4EZ5 0 JRNL AUTH Y.S.CHO,H.ANGOVE,C.BRAIN,C.H.CHEN,H.CHENG,R.CHENG,R.CHOPRA, JRNL AUTH 2 K.CHUNG,M.CONGREVE,C.DAGOSTIN,D.J.DAVIS,R.FELTELL, JRNL AUTH 3 J.GIRALDES,S.D.HISCOCK,S.KIM,S.KOVATS,B.LAGU,K.LEWRY,A.LOO, JRNL AUTH 4 Y.LU,M.LUZZIO,W.MANIARA,R.MCMENAMIN,P.N.MORTENSON,R.BENNING, JRNL AUTH 5 M.O'REILLY,D.C.REES,J.SHEN,T.SMITH,Y.WANG,G.WILLIAMS, JRNL AUTH 6 A.J.WOOLFORD,W.WRONA,M.XU,F.YANG,S.HOWARD JRNL TITL FRAGMENT-BASED DISCOVERY OF 7-AZABENZIMIDAZOLES AS POTENT, JRNL TITL 2 HIGHLY SELECTIVE, AND ORALLY ACTIVE CDK4/6 INHIBITORS. JRNL REF ACS MED CHEM LETT V. 3 445 2012 JRNL REFN ISSN 1948-5875 JRNL PMID 24900493 JRNL DOI 10.1021/ML200241A REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.7.3_928 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.63 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 8616 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.740 REMARK 3 FREE R VALUE TEST SET COUNT : 408 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.6259 - 3.8880 1.00 2792 129 0.1997 0.2529 REMARK 3 2 3.8880 - 3.0900 1.00 2718 146 0.2186 0.3367 REMARK 3 3 3.0900 - 2.7005 1.00 2698 133 0.3360 0.4080 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.98 REMARK 3 K_SOL : 0.32 REMARK 3 B_SOL : 62.08 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.560 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 34.360 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 93.82 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 10.14640 REMARK 3 B22 (A**2) : 10.14640 REMARK 3 B33 (A**2) : -20.29290 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 2148 REMARK 3 ANGLE : 0.948 2909 REMARK 3 CHIRALITY : 0.061 326 REMARK 3 PLANARITY : 0.005 367 REMARK 3 DIHEDRAL : 14.314 790 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4EZ5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAY-12. REMARK 100 THE DEPOSITION ID IS D_1000072251. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : D*TREK 9.9.3L REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8618 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 7.460 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3NUP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.25 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES PH 6.0, 12% PEG-3350, 0.1M REMARK 280 NH4NO3, EVAPORATION, TEMPERATURE 298K, VAPOR DIFFUSION, HANGING REMARK 280 DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 4 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -Y,X,Z REMARK 290 4555 Y,-X,Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -Y+1/2,X+1/2,Z+1/2 REMARK 290 8555 Y+1/2,-X+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 51.23900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 51.23900 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 29.99350 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 51.23900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 51.23900 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 29.99350 REMARK 290 SMTRY1 7 0.000000 -1.000000 0.000000 51.23900 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 51.23900 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 29.99350 REMARK 290 SMTRY1 8 0.000000 1.000000 0.000000 51.23900 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 51.23900 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 29.99350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 LYS A 3 REMARK 465 ASP A 4 REMARK 465 GLY A 5 REMARK 465 LEU A 6 REMARK 465 CYS A 7 REMARK 465 ARG A 8 REMARK 465 ALA A 9 REMARK 465 ASP A 10 REMARK 465 TYR A 24 REMARK 465 ARG A 46 REMARK 465 VAL A 47 REMARK 465 GLN A 48 REMARK 465 THR A 49 REMARK 465 GLY A 50 REMARK 465 GLU A 51 REMARK 465 GLU A 52 REMARK 465 GLY A 53 REMARK 465 MET A 54 REMARK 465 VAL A 85 REMARK 465 SER A 86 REMARK 465 ARG A 87 REMARK 465 THR A 88 REMARK 465 ASP A 89 REMARK 465 ARG A 90 REMARK 465 GLU A 91 REMARK 465 THR A 92 REMARK 465 ARG A 168 REMARK 465 ILE A 169 REMARK 465 TYR A 170 REMARK 465 SER A 171 REMARK 465 PHE A 172 REMARK 465 GLN A 173 REMARK 465 MET A 174 REMARK 465 ALA A 175 REMARK 465 LEU A 176 REMARK 465 THR A 177 REMARK 465 SER A 178 REMARK 465 VAL A 179 REMARK 465 VAL A 180 REMARK 465 SER A 256 REMARK 465 LYS A 257 REMARK 465 HIS A 302 REMARK 465 HIS A 303 REMARK 465 HIS A 304 REMARK 465 HIS A 305 REMARK 465 HIS A 306 REMARK 465 HIS A 307 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 72 64.14 35.80 REMARK 500 PRO A 115 39.50 -95.85 REMARK 500 ARG A 144 -19.68 81.36 REMARK 500 SER A 155 -40.88 -28.03 REMARK 500 SER A 194 -49.95 -133.50 REMARK 500 ALA A 197 -166.67 -77.02 REMARK 500 ARG A 215 1.55 59.85 REMARK 500 ASP A 268 -18.57 92.41 REMARK 500 PHE A 300 47.66 -97.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0RS A 900 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3NUP RELATED DB: PDB REMARK 900 RELATED ID: 3NUX RELATED DB: PDB DBREF 4EZ5 A 1 301 UNP Q00534 CDK6_HUMAN 1 301 SEQADV 4EZ5 HIS A 302 UNP Q00534 EXPRESSION TAG SEQADV 4EZ5 HIS A 303 UNP Q00534 EXPRESSION TAG SEQADV 4EZ5 HIS A 304 UNP Q00534 EXPRESSION TAG SEQADV 4EZ5 HIS A 305 UNP Q00534 EXPRESSION TAG SEQADV 4EZ5 HIS A 306 UNP Q00534 EXPRESSION TAG SEQADV 4EZ5 HIS A 307 UNP Q00534 EXPRESSION TAG SEQRES 1 A 307 MET GLU LYS ASP GLY LEU CYS ARG ALA ASP GLN GLN TYR SEQRES 2 A 307 GLU CYS VAL ALA GLU ILE GLY GLU GLY ALA TYR GLY LYS SEQRES 3 A 307 VAL PHE LYS ALA ARG ASP LEU LYS ASN GLY GLY ARG PHE SEQRES 4 A 307 VAL ALA LEU LYS ARG VAL ARG VAL GLN THR GLY GLU GLU SEQRES 5 A 307 GLY MET PRO LEU SER THR ILE ARG GLU VAL ALA VAL LEU SEQRES 6 A 307 ARG HIS LEU GLU THR PHE GLU HIS PRO ASN VAL VAL ARG SEQRES 7 A 307 LEU PHE ASP VAL CYS THR VAL SER ARG THR ASP ARG GLU SEQRES 8 A 307 THR LYS LEU THR LEU VAL PHE GLU HIS VAL ASP GLN ASP SEQRES 9 A 307 LEU THR THR TYR LEU ASP LYS VAL PRO GLU PRO GLY VAL SEQRES 10 A 307 PRO THR GLU THR ILE LYS ASP MET MET PHE GLN LEU LEU SEQRES 11 A 307 ARG GLY LEU ASP PHE LEU HIS SER HIS ARG VAL VAL HIS SEQRES 12 A 307 ARG ASP LEU LYS PRO GLN ASN ILE LEU VAL THR SER SER SEQRES 13 A 307 GLY GLN ILE LYS LEU ALA ASP PHE GLY LEU ALA ARG ILE SEQRES 14 A 307 TYR SER PHE GLN MET ALA LEU THR SER VAL VAL VAL THR SEQRES 15 A 307 LEU TRP TYR ARG ALA PRO GLU VAL LEU LEU GLN SER SER SEQRES 16 A 307 TYR ALA THR PRO VAL ASP LEU TRP SER VAL GLY CYS ILE SEQRES 17 A 307 PHE ALA GLU MET PHE ARG ARG LYS PRO LEU PHE ARG GLY SEQRES 18 A 307 SER SER ASP VAL ASP GLN LEU GLY LYS ILE LEU ASP VAL SEQRES 19 A 307 ILE GLY LEU PRO GLY GLU GLU ASP TRP PRO ARG ASP VAL SEQRES 20 A 307 ALA LEU PRO ARG GLN ALA PHE HIS SER LYS SER ALA GLN SEQRES 21 A 307 PRO ILE GLU LYS PHE VAL THR ASP ILE ASP GLU LEU GLY SEQRES 22 A 307 LYS ASP LEU LEU LEU LYS CYS LEU THR PHE ASN PRO ALA SEQRES 23 A 307 LYS ARG ILE SER ALA TYR SER ALA LEU SER HIS PRO TYR SEQRES 24 A 307 PHE GLN HIS HIS HIS HIS HIS HIS HET 0RS A 900 36 HETNAM 0RS {5-[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]-1H-IMIDAZO[4,5- HETNAM 2 0RS B]PYRIDIN-2-YL}[2-(ISOQUINOLIN-4-YL)PYRIDIN-4- HETNAM 3 0RS YL]METHANONE FORMUL 2 0RS C28 H27 N7 O HELIX 1 1 LYS A 34 GLY A 36 5 3 HELIX 2 2 LEU A 56 PHE A 71 1 16 HELIX 3 3 LEU A 105 LYS A 111 1 7 HELIX 4 4 PRO A 118 HIS A 139 1 22 HELIX 5 5 ALA A 187 GLN A 193 1 7 HELIX 6 6 PRO A 199 ARG A 215 1 17 HELIX 7 7 SER A 223 GLY A 236 1 14 HELIX 8 8 GLY A 239 TRP A 243 5 5 HELIX 9 9 PRO A 250 PHE A 254 5 5 HELIX 10 10 ASP A 270 LEU A 281 1 12 HELIX 11 11 SER A 290 LEU A 295 1 6 HELIX 12 12 HIS A 297 GLN A 301 5 5 SHEET 1 A 5 TYR A 13 GLU A 21 0 SHEET 2 A 5 LYS A 26 ASP A 32 -1 O LYS A 29 N VAL A 16 SHEET 3 A 5 PHE A 39 ARG A 44 -1 O LEU A 42 N PHE A 28 SHEET 4 A 5 THR A 95 GLU A 99 -1 O LEU A 96 N LYS A 43 SHEET 5 A 5 LEU A 79 CYS A 83 -1 N CYS A 83 O THR A 95 SHEET 1 B 3 GLN A 103 ASP A 104 0 SHEET 2 B 3 ILE A 151 VAL A 153 -1 O VAL A 153 N GLN A 103 SHEET 3 B 3 ILE A 159 LEU A 161 -1 O LYS A 160 N LEU A 152 CISPEP 1 GLU A 114 PRO A 115 0 -2.19 SITE 1 AC1 16 ILE A 19 VAL A 27 LYS A 43 VAL A 77 SITE 2 AC1 16 PHE A 98 GLU A 99 HIS A 100 VAL A 101 SITE 3 AC1 16 ASP A 102 ASP A 104 THR A 107 GLN A 149 SITE 4 AC1 16 ASN A 150 LEU A 152 ALA A 162 ASP A 163 CRYST1 102.478 102.478 59.987 90.00 90.00 90.00 I 4 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009758 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009758 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016670 0.00000